Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)

Small Molecules Studied

  • Page 1 of 4
  • 1 to 25 of 95 Small Molecules
HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10506-1 Dichloroacetate 25975
10513-1 Nelfinavir
Viracept
64143
10516-1 Ribavirin
Tribavirin
37542
10514-1 PS-1145 9949093
10507-1 Disulfiram
Tetraethylthiuram disulfide; TETD
3117
10511-1 Mebendazole
Vermox
4030
10508-1 FTase Inhibitor I
B581
132887
10520-1 TCS PIM-1 1 1235170
10276-1 TCS 2312 LSM-6362 11258443
10247-1 Docetaxel
Taxotere
LSM-6360 148124
10237-1 5-DFUR
5-FdUR; Doxifluridine
LSM-6359 18343
10348-1 Z-Leu-Leu-Norvalinal
MG-115
LSM-6358 9868928
10345-3 Torkinib
PP242
LSM-6357 57347681
10344-1 Olomoucine II LSM-6356 10067756
10343-1 Baicalein LSM-6355 5281605
10272-1 Pemetrexed
Alimta
LSM-6353 446556
10268-1 Nutlin 3a LSM-6351 11433190
10250-1 Etoposide LSM-6348 36462
10281-1 Vinorelbine
Navelbine
LSM-6302 5311497
10241 Bortezomib
Velcade
LSM-6281 387447
10241-4 Bortezomib
Velcade
LSM-6281 387447
10241-1 Bortezomib
Velcade
LSM-6281 387447
10265-1 Pevonedistat
MLN 4924; MLN-4924; MLN4924
LSM-6263 16720766
10260-1 Ispinesib
SB-715992
LSM-5732 6851740
10264-1 Methotrexate
Rheumatrex; Trexall; Amethopterin; MTX
LSM-5690 126941
  • Page 1 of 4
  • 1 to 25 of 95 Small Molecules